150 related articles for article (PubMed ID: 22425904)
1. Carbocyclic thymidine derivatives efficiently inhibit Plasmodium falciparum thymidylate kinase (PfTMK).
Kato A; Yasuda Y; Kitamura Y; Kandeel M; Kitade Y
Parasitol Int; 2012 Sep; 61(3):501-3. PubMed ID: 22425904
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of carbocyclic pyrimidine nucleosides and their inhibitory activities against Plasmodium falciparum thymidylate kinase.
Noguchi Y; Yasuda Y; Tashiro M; Kataoka T; Kitamura Y; Kandeel M; Kitade Y
Parasitol Int; 2013 Aug; 62(4):368-71. PubMed ID: 23583697
[TBL] [Abstract][Full Text] [Related]
3. Thymidylate kinase: the lost chemotherapeutic target.
Kandeel M; Kato A; Kitamura Y; Kitade Y
Nucleic Acids Symp Ser (Oxf); 2009; (53):283-4. PubMed ID: 19749371
[TBL] [Abstract][Full Text] [Related]
4. Potential application of thymidylate kinase in nucleoside analogue activation in Plasmodium falciparum.
Cui H; Ruiz-Pérez LM; González-Pacanowska D; Gilbert IH
Bioorg Med Chem; 2010 Oct; 18(20):7302-9. PubMed ID: 20833052
[TBL] [Abstract][Full Text] [Related]
5. Mutational, inhibitory and microcalorimetric analyses of Plasmodium falciparum TMP kinase. Implications for drug discovery.
Kandeel M; Ando T; Kitamura Y; Abdel-Aziz M; Kitade Y
Parasitology; 2009 Jan; 136(1):11-25. PubMed ID: 19126267
[TBL] [Abstract][Full Text] [Related]
6. Interaction of α-Thymidine Inhibitors with Thymidylate Kinase from Plasmodium falciparum.
Chen MD; Sinha K; Rule GS; Ly DH
Biochemistry; 2018 May; 57(19):2868-2875. PubMed ID: 29684273
[TBL] [Abstract][Full Text] [Related]
7. The substrate binding preferences of Plasmodium thymidylate kinase.
Kandeel M; Kitade Y
Biol Pharm Bull; 2011; 34(1):173-6. PubMed ID: 21212540
[TBL] [Abstract][Full Text] [Related]
8. The structural basis of unique substrate recognition by Plasmodium thymidylate kinase: Molecular dynamics simulation and inhibitory studies.
Kandeel M; Kitade Y; Al-Taher A; Al-Nazawi M
PLoS One; 2019; 14(2):e0212065. PubMed ID: 30730992
[TBL] [Abstract][Full Text] [Related]
9. Structural basis for the efficient phosphorylation of AZT-MP (3'-azido-3'-deoxythymidine monophosphate) and dGMP by Plasmodium falciparum type I thymidylate kinase.
Whittingham JL; Carrero-Lerida J; Brannigan JA; Ruiz-Perez LM; Silva AP; Fogg MJ; Wilkinson AJ; Gilbert IH; Wilson KS; González-Pacanowska D
Biochem J; 2010 May; 428(3):499-509. PubMed ID: 20353400
[TBL] [Abstract][Full Text] [Related]
10. dGMP Binding to Thymidylate Kinase from
Chen MD; Fucci IJ; Sinha K; Rule GS
Biochemistry; 2020 Feb; 59(5):694-703. PubMed ID: 31934749
[No Abstract] [Full Text] [Related]
11. Molecular characterization, heterologous expression and kinetic analysis of recombinant Plasmodium falciparum thymidylate kinase.
Kandeel M; Kitade Y
J Biochem; 2008 Aug; 144(2):245-50. PubMed ID: 18477629
[TBL] [Abstract][Full Text] [Related]
12. First report on exploring structural requirements of α and β thymidine analogs for PfTMPK inhibitory activity using in silico studies.
Ojha PK; Roy K
Biosystems; 2013 Sep; 113(3):177-95. PubMed ID: 23850534
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and evaluation of 6-aza-2'-deoxyuridine monophosphate analogs as inhibitors of thymidylate synthases, and as substrates or inhibitors of thymidine monophosphate kinase in Mycobacterium tuberculosis.
Kögler M; Busson R; De Jonghe S; Rozenski J; Van Belle K; Louat T; Munier-Lehmann H; Herdewijn P
Chem Biodivers; 2012 Mar; 9(3):536-56. PubMed ID: 22422522
[TBL] [Abstract][Full Text] [Related]
14. Substrate specificity of vaccinia virus thymidylate kinase.
Topalis D; Collinet B; Gasse C; Dugué L; Balzarini J; Pochet S; Deville-Bonne D
FEBS J; 2005 Dec; 272(24):6254-65. PubMed ID: 16336263
[TBL] [Abstract][Full Text] [Related]
15. Novel antiviral C5-substituted pyrimidine acyclic nucleoside phosphonates selected as human thymidylate kinase substrates.
Topalis D; Pradère U; Roy V; Caillat C; Azzouzi A; Broggi J; Snoeck R; Andrei G; Lin J; Eriksson S; Alexandre JA; El-Amri C; Deville-Bonne D; Meyer P; Balzarini J; Agrofoglio LA
J Med Chem; 2011 Jan; 54(1):222-32. PubMed ID: 21128666
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and inhibitory activity of thymidine analogues targeting Mycobacterium tuberculosis thymidine monophosphate kinase.
Van Poecke S; Munier-Lehmann H; Helynck O; Froeyen M; Van Calenbergh S
Bioorg Med Chem; 2011 Dec; 19(24):7603-11. PubMed ID: 22061826
[TBL] [Abstract][Full Text] [Related]
17. The exceptional properties of Plasmodium deoxyguanylate pathways as a potential area for metabolic and drug discovery studies.
Kandeel M; Kitamura Y; Kitade Y
Nucleic Acids Symp Ser (Oxf); 2009; (53):39-40. PubMed ID: 19749249
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of α-thymidine analogues as novel antimalarials.
Cui H; Carrero-Lérida J; Silva AP; Whittingham JL; Brannigan JA; Ruiz-Pérez LM; Read KD; Wilson KS; González-Pacanowska D; Gilbert IH
J Med Chem; 2012 Dec; 55(24):10948-57. PubMed ID: 23240776
[TBL] [Abstract][Full Text] [Related]
19. Thymidine and thymidine-5'-O-monophosphate analogues as inhibitors of Mycobacterium tuberculosis thymidylate kinase.
Vanheusden V; Van Rompaey P; Munier-Lehmann H; Pochet S; Herdewijn P; Van Calenbergh S
Bioorg Med Chem Lett; 2003 Sep; 13(18):3045-8. PubMed ID: 12941330
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of 2-modified aristeromycins and their analogs as potent inhibitors against Plasmodium falciparum S-adenosyl-L-homocysteine hydrolase.
Ando T; Iwata M; Zulfiqar F; Miyamoto T; Nakanishi M; Kitade Y
Bioorg Med Chem; 2008 Apr; 16(7):3809-15. PubMed ID: 18295495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
